"The response from investors exceeded our expectations and it shows how well Elekta is perceived in the financial community. We did a private placement in 2005 of 125 million US dollar and with this additional private placement Elekta has secured a well structured long term financing", says Tomas Puusepp, President and CEO of Elekta.
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 18.00 CET on May 5, 2011.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
This information was brought to you by Cision http://www.cisionwire.com
Contact:
Elekta AB Stina Thorman, Vice President Corporate Communications, Tel: +46 8 587 254 37 Email: stina.thorman@elekta.com
